Evidence map›Paper›PMID 40543679›Full record

ArticleJournal of vascular surgery2025

Comparative effectiveness of suction thrombectomy versus catheter-directed thrombolysis in intermediate-risk pulmonary embolism.

Fanny S Alie-Cusson, Marissa Jarosinski, Katherine M Reitz, Pamela El Hayek, Hind Anan, Dana Semaan, Elizabeth Andraska, Belinda Rivera-Lebron, Rabih Chaer, Natalie D Sridharan

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of vascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fanny S Alie-CussonDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Marissa JarosinskiDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Katherine M ReitzDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Pamela El HayekDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Hind AnanDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Dana SemaanDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Elizabeth AndraskaDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Belinda Rivera-LebronDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA.
Rabih ChaerDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Natalie D SridharanDivision of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: domenickana2@upmc.edu.

Funding

Vascular Surgery Research Training (VascTrain) ProgramT32HL098036 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Edith Tzeng · 2010 to 2026
$7.2M
NHLBI NIH HHS T32 HL098036
6 · The paper itself

Abstract

objectiveCatheter-directed thrombolysis (CDT) has been shown to rapidly reverse hemodynamic and echocardiographic abnormalities seen in intermediate-risk pulmonary embolism (IRPE). Suction thrombectomy (ST) devices have emerged as alternative treatment modalities demonstrating immediate results, obviating the need for thrombolytics. Comparative data between the two methods are sparse.

methodsWe retrospectively reviewed interventions for IRPE (CDT or ST) at a multihospital health care system (2017-2022). IRPE was defined by evidence of right heart strain (RHS) on imaging (echocardiogram and/or computed tomography angiography) or elevated biomarkers (troponin or B-natriuretic peptide). Patients with high-risk PE (systolic blood pressure <90 mmHg) or those who received systemic thrombolytics were excluded. The primary endpoint was a composite of 7-day all-cause mortality, intracranial bleeding, major bleeding, clinical deterioration, and/or need for bailout therapy. Secondary outcomes included the primary endpoint individual components, intensive care unit length of stay, 30-day mortality, and resolution of RHS at 3 months. Inverse probability of treatment weighting (IPTW) was used to adjust for baseline imbalances between groups, generating weighted odds ratios (wORs).

resultsA total of 332 patients were included, with 152 patients with CDT and 180 with ST. IPTW successfully balanced baseline differences between groups (Table I). On univariable analysis, the primary outcome did not differ between groups (CDT 6.6% vs ST 12.8%; P = .06), but ST was associated with increased 30-day mortality (CDT 1.3% vs ST 5.5%; P = .039) and the need for bailout intervention (CDT 4.6% vs ST 11.1%; P = .031). Major bleeding occurred in 3.3% CDT vs 2.2% ST (P = .551). There were no intracranial bleeds. Post-IPTW analysis showed a significantly higher rate of the primary outcome in the ST group (wOR, 4.4; 95% confidence interval [CI], 1.27-15.3; P = .02). There were no differences in 7-day mortality, 30-day mortality, major bleeding, or intracranial bleeding. The need for bailout intervention was significantly higher in the ST group (wOR, 3.7; 95% CI, 1.04-13.4; P = .044). The use of ST was significantly associated with resolution of RHS (wOR, 3.46; 95% CI, 1.32-9.11; P = .012).

conclusionsST is associated with significantly increased odds of the primary outcome in patients with IRPE when compared with CDT after IPTW. These results were mainly driven by the bailout intervention rate. There was no statistically significant reduction in major bleeding or intensive care unit length of stay compared with CDT. RHS resolved more frequently in patients after ST, suggesting there may be benefit to rapid thrombus removal in appropriately selected patients with IPRE despite the increased need for bailout therapy. CDT should remain an integral part of the interventional armamentarium in IRPE.

Indexed as

Fibrinolytic AgentsPulmonary EmbolismThrombectomyThrombolytic TherapyAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsSuctionTime FactorsTreatment OutcomeFibrinolytic AgentsAcute pulmonary embolismCatheter-directed interventionsCatheter-directed thrombolysisIntermediate-riskMechanical thrombectomySubmassiveSuction thrombectomyVenous thromboembolism

Identifiers

PMID40543679
PMCPMC13102487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.